Market News & Trends
North American Drug Delivery Technologies Market Worth $102.2 Billion by 2017
Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time…
Greek Market to Show Modest Growth; Indian Market to Reach $56 billion
The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek pharmaceutical market, which will increase from approximately $7.8 billion in…
Bright Future Ahead for Biopharmaceutical Contract Manufacturing
Considerable growth opportunities lie ahead for biopharmaceutical contract manufacturing organizations (CMOs). With blockbuster biologics worth over $100 billion due to lose patent protection by 2019,…
Gallus Strengthens Biologics CMO Business With Acquisition
Gallus BioPharmaceuticals, LLC recently announced its acquisition of Laureate Biopharmaceutical Services, Inc., a full-service biologics CMO located in Princeton, NJ. This acquisition doubles Gallus’ process…
Effimune Announces Major Global License Agreement
Effimune recently announced a global option and license agreement with Janssen Biotech, Inc. The collaboration between Effimune, the London Innovation Centre of Johnson & Johnson…
Cambridge Major Laboratories & AAIPharma Services Announce Merger
Cambridge Major Laboratories, Inc. and AAIPharma Services Corp. recently announced their intent to merge to form the premier global supplier of integrated CMC services. Financial…
Hovione Announces Successful Inspection
Hovione's plant in Loures, Portugal, has successfully passed a GMP and Postmarket Approval inspection by FDA. The inspection, carried out by Mrs. Yumi Hiramine, Inspector…
British Pharmaceutical Market to Reach $31.7 Billion
A growing disease burden, universal coverage, and good access to healthcare facilities are boosting the UK healthcare market; but increasing use of generics and government…
ProStrakan Launches First Transdermal CINV Drug; 3M DDS to Manufacture
The European Medicines Agency (EMA) has recently granted approval for ProStrakan Group plc to market SANCUSO (Granisetron Transdermal System) in the European Union (EU), with…
Capsugel Expands Global Manufacturing for Finished Dosage Forms
Capsugel’s Dosage Form Solutions (DFS) business unit unveiled extensive upgrades and expansions to three of its manufacturing facilities in the US and Europe, deepening the…
West Dedicates Second Manufacturing Plant in China
West Pharmaceutical Services, Inc. hosted a dedication ceremony to mark the start-up of its recently completed compression molding plant in the Shanghai Zhangjiang High-Tech Industrial…
NanoSight Acquired by Malvern Instruments
NanoSight Ltd recently announced it has been acquired by Malvern Instruments Ltd with the acquisition being completed on September 27. NanoSight has developed and commercialized…
Catalent Announces Expansion to Improve Bioavailability
Catalent Pharma Solutions recently announced several advancements and expansion of its OptiMelt Hot Melt Extrusion (HME) capabilities in Somerset, NJ. Catalent’s OptiMelt technology is designed…
JHP Pharmaceuticals Enters Ophthalmic Manufacturing Agreement
JHP Pharmaceuticals recently announced it has entered into a manufacturing agreement with an undisclosed pharmaceutical company, which has developed proprietary products that provide sustained and…
Mystic Pharmaceuticals Receives Multiple Patent Allowance on Platform Technologies
Mystic Pharmaceuticals, Inc. recently announced it has received two Notices of Allowance from the US Patent Office for its Unit Dose Drug Delivery Platform (serial…
Veritas Bio’s RNA Delivery Patent Allowed
Veritas Bio, LLC, recently announce that the European Patent Office (EPO) has granted a patent to Veritas for European Patent Application No. 07 873 598.2…
Supernus & Catalent Enter Supply Agreement
Catalent Pharma Solutions and Supernus Pharmaceuticals recently announced they have entered into an agreement in which Catalent is the supplier of Trokendi XR extended-release capsules…
Capsugel Expands Global Manufacturing for Finished Dosage Forms
Capsugel’s Dosage Form Solutions (DFS) business unit recently unveiled extensive upgrades and expansions to three of its manufacturing facilities in the US and Europe, deepening…
Chiesi Farmaceutici SpA & Cornerstone Therapeutics Announce Merger Transaction
Chiesi Farmaceutici S.p.A. and Cornerstone Therapeutics Inc. recently announced that the special committee of the Cornerstone Board of Directors, as well as the boards of…
AstraZeneca Pays $50 Million Up-Front for Cancer Drug
Merck and AstraZeneca recently announced a worldwide licensing agreement for Merck’s oral small molecule inhibitor of WEE1 kinase (MK-1775). MK-1775 is currently being evaluated in…
